Trial Details

Not Recruiting
Basic Information
Clinical ID c2253
Identifier EUCTR2022-000837-17-NL
Trial Title Subcutaneous vedolizumab drug de-escalation using therapeutic drug monitoring in inflammatory bowel disease: a randomized controlled pilot study - SILVER-study
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory bowel diseases (Crohn's disease, ulcerative colitis);Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: Vedolizumab, Entyvio Pharmaceutical Form: Injection
Participant Information
Sponsor Amsterdam UMC
City -
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -